Wei et al. also indicated that phosphorylated CD133 could interact with p85 and activate the PI3K/Akt signal pathway, which results in the increased tumorigenic capacity and stemness genes in glioma stem cells [50]. This evidence concerns the gene AKT1 and central nervous system cancer.